Euro vs US Dollar

Registrieren Sie sich, um in unseren aktiven Foren mit gleichgesinnten Anlegern zu diskutieren.

Registrieren

WLLW

Willow Biosciences (WLLW)

Willow Biosciences Inc

Von:

Regulatory News

Text Search:

Sortieren nach:

Non-Regulatory News

Showing the most relevant articles for your search:TSX:WLLW

1 2 3 4 5 6 7 Next >>

Datum	Zeit	Quelle	Überschrift	Symbol	Firma
12/11/2024	13h00	PR Newswire (Canada)	WILLOW BIOSCIENCES REPORTS THIRD QUARTER 2024 FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE	TSX:WLLW	Willow Biosciences Inc
12/11/2024	13h00	PR Newswire (US)	WILLOW BIOSCIENCES REPORTS THIRD QUARTER 2024 FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE	TSX:WLLW	Willow Biosciences Inc
07/11/2024	13h00	PR Newswire (US)	WILLOW BIOSCIENCES ANNOUNCES NEW PARTNERSHIP WITH A GLOBAL INGREDIENT MANUFACTURER TO ADVANCE DEVELOPMENT OF A HIGH VALUE INGREDIENT FROM ITS PORTFOLIO	TSX:WLLW	Willow Biosciences Inc
07/11/2024	13h00	PR Newswire (Canada)	WILLOW BIOSCIENCES ANNOUNCES NEW PARTNERSHIP WITH A GLOBAL INGREDIENT MANUFACTURER TO ADVANCE DEVELOPMENT OF A HIGH VALUE INGREDIENT FROM ITS PORTFOLIO	TSX:WLLW	Willow Biosciences Inc
19/09/2024	01h00	PR Newswire (Canada)	WILLOW ANNOUNCES A SECOND PROGRAM WITH GLOBAL INGREDIENT MANUFACTURER TO DEVELOP AN ENZYME FOR MANUFACTURING A LARGE VOLUME ACTIVE PHARMACEUTICAL INGREDIENT	TSX:WLLW	Willow Biosciences Inc
19/09/2024	01h00	PR Newswire (US)	WILLOW ANNOUNCES A SECOND PROGRAM WITH GLOBAL INGREDIENT MANUFACTURER TO DEVELOP AN ENZYME FOR MANUFACTURING A LARGE VOLUME ACTIVE PHARMACEUTICAL INGREDIENT	TSX:WLLW	Willow Biosciences Inc
05/09/2024	19h00	AllPennyStocks.com	Biotech on An Upswing Following Licensing and Royalty Agreement	TSX:WLLW	Willow Biosciences Inc
05/09/2024	13h00	PR Newswire (US)	WILLOW ANNOUNCES COMMERCIAL LICENSE AND ROYALTY AGREEMENT WITH KALSEC INC.	TSX:WLLW	Willow Biosciences Inc
05/09/2024	13h00	PR Newswire (Canada)	WILLOW ANNOUNCES COMMERCIAL LICENSE AND ROYALTY AGREEMENT WITH KALSEC INC.	TSX:WLLW	Willow Biosciences Inc
12/08/2024	13h00	PR Newswire (US)	WILLOW BIOSCIENCES REPORTS SECOND QUARTER 2024 FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE	TSX:WLLW	Willow Biosciences Inc
12/08/2024	13h00	PR Newswire (Canada)	WILLOW BIOSCIENCES REPORTS SECOND QUARTER 2024 FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE	TSX:WLLW	Willow Biosciences Inc
07/08/2024	13h00	PR Newswire (US)	WILLOW BIOSCIENCES ANNOUNCES NEW FUNDED BIOPESTICIDES RESEARCH AND DEVELOPMENT PARTNERSHIP AFTER SUCCESSFULLY COMPLETING FEASIBILITY STUDY	TSX:WLLW	Willow Biosciences Inc
07/08/2024	13h00	PR Newswire (Canada)	WILLOW BIOSCIENCES ANNOUNCES NEW FUNDED BIOPESTICIDES RESEARCH AND DEVELOPMENT PARTNERSHIP AFTER SUCCESSFULLY COMPLETING FEASIBILITY STUDY	TSX:WLLW	Willow Biosciences Inc
26/07/2024	23h48	PR Newswire (Canada)	WILLOW BIOSCIENCES ANNOUNCES ANNUAL GENERAL AND SPECIAL MEETING VOTING RESULTS	TSX:WLLW	Willow Biosciences Inc
18/07/2024	14h49	PR Newswire (Canada)	WILLOW BIOSCIENCES ANNOUNCES CLOSING OF PRIVATE PLACEMENT OF UNITS	TSX:WLLW	Willow Biosciences Inc
26/06/2024	22h30	PR Newswire (Canada)	WILLOW BIOSCIENCES PROVIDES CORPORATE UPDATE AND ANNOUNCES SIGNING OF A NEW PARTNERED PROGRAM	TSX:WLLW	Willow Biosciences Inc
26/06/2024	22h30	PR Newswire (US)	WILLOW BIOSCIENCES PROVIDES CORPORATE UPDATE AND ANNOUNCES SIGNING OF A NEW PARTNERED PROGRAM	TSX:WLLW	Willow Biosciences Inc
03/06/2024	13h00	PR Newswire (Canada)	WILLOW ANNOUNCES BROKERED PRIVATE PLACEMENT OFFERING TO RAISE UP TO $3.0 MILLION	TSX:WLLW	Willow Biosciences Inc
30/05/2024	13h00	PR Newswire (US)	WILLOW ANNOUNCES MULTI-PRODUCT DEVELOPMENT AND LICENSING PARTNERSHIP WITH LAURUS LABS FOR MANUFACTURING ACTIVE PHARMACEUTICAL INGREDIENTS	TSX:WLLW	Willow Biosciences Inc
30/05/2024	13h00	PR Newswire (Canada)	WILLOW ANNOUNCES MULTI-PRODUCT DEVELOPMENT AND LICENSING PARTNERSHIP WITH LAURUS LABS FOR MANUFACTURING ACTIVE PHARMACEUTICAL INGREDIENTS	TSX:WLLW	Willow Biosciences Inc
13/05/2024	13h00	PR Newswire (US)	WILLOW BIOSCIENCES REPORTS FIRST QUARTER 2024 FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE	TSX:WLLW	Willow Biosciences Inc
13/05/2024	13h00	PR Newswire (Canada)	WILLOW BIOSCIENCES REPORTS FIRST QUARTER 2024 FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE	TSX:WLLW	Willow Biosciences Inc
29/03/2024	00h30	PR Newswire (Canada)	WILLOW BIOSCIENCES REPORTS FOURTH QUARTER AND FISCAL YEAR 2023 FINANCIALS AND OPERATIONS AND FILING OF ITS 2023 AIF	TSX:WLLW	Willow Biosciences Inc
29/03/2024	00h30	PR Newswire (US)	WILLOW BIOSCIENCES REPORTS FOURTH QUARTER AND FISCAL YEAR 2023 FINANCIALS AND OPERATIONS AND FILING OF ITS 2023 AIF	TSX:WLLW	Willow Biosciences Inc
01/03/2024	00h00	PR Newswire (Canada)	WILLOW BIOSCIENCES ANNOUNCES SECOND STRATEGIC INVESTMENT FROM KALSEC	TSX:WLLW	Willow Biosciences Inc
01/03/2024	00h00	PR Newswire (US)	WILLOW BIOSCIENCES ANNOUNCES SECOND STRATEGIC INVESTMENT FROM KALSEC	TSX:WLLW	Willow Biosciences Inc
21/02/2024	00h00	PR Newswire (Canada)	WILLOW BIOSCIENCES ANNOUNCES STRATEGIC INVESTMENT FROM KALSEC TO DEVELOP INNOVATIVE NATURAL FOOD INGREDIENTS	TSX:WLLW	Willow Biosciences Inc
21/02/2024	00h00	PR Newswire (US)	WILLOW BIOSCIENCES ANNOUNCES STRATEGIC INVESTMENT FROM KALSEC TO DEVELOP INNOVATIVE NATURAL FOOD INGREDIENTS	TSX:WLLW	Willow Biosciences Inc
31/01/2024	13h00	PR Newswire (US)	WILLOW ANNOUNCES COLLABORATION WITH GLOBAL INGREDIENT MANUFACTURER TO DEVELOP A MORE COST-EFFECTIVE, SUSTAINABLE PROCESS FOR A LARGE VOLUME ACTIVE PHARMACEUTICAL INGREDIENT	TSX:WLLW	Willow Biosciences Inc
31/01/2024	13h00	PR Newswire (Canada)	WILLOW ANNOUNCES COLLABORATION WITH GLOBAL INGREDIENT MANUFACTURER TO DEVELOP A MORE COST-EFFECTIVE, SUSTAINABLE PROCESS FOR A LARGE VOLUME ACTIVE PHARMACEUTICAL INGREDIENT	TSX:WLLW	Willow Biosciences Inc

Showing the most relevant articles for your search:TSX:WLLW

1 2 3 4 5 6 7 Next >>

Omnicom FInance

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen